[Posttraumatic eosinophilic fasciitis: diagnostic usefulness of magnetic resonance imaging].

1. Martín JM, Ramón D, Monteagudo C, Llombart B, Castelló A, Molina I, et al. Lupus eritematoso cutáneo subagudo inducido por fármacos. Actas Dermosifiliogr. 2004;95:117--9. 2. Callen JP. Drug-induced subacute cutaneous lupus erythematosus. Lupus. 2010;19:1107--11. 3. Marzano AV, Vezzoli P, Crosti C. Drug-induced lupus: an update on its dermatologic aspects. Lupus. 2009;18:935--40. 4. Callen JP. Drug-induced cutaneous lupus erythematosus, a distinct syndrome that is frequently unrecognized. J Am Acad Dermatol. 2001;45:315--6. 5. Srivastava M, Rencic A, Diglio G, Santana H, Bonitz P, Watson R, et al. Drug-induced, Ro /SSA-positive cutaneous lupus erythematosus. Arch Dermatol. 2003;139:45--9. 6. Dam C, Bygum A. Subacute cutaneous lupus erythematosus induced or exacerbated by proton pump inhibitors. Acta Derm Venereol. 2008;88:87--9. 7. Bracke A, Nijsten T, Vandermaesen J, Meuleman L, Lambert J. Lansoprazole-induced subacute cutaneous lupus erythematosus: two cases. Acta Derm Venereol. 2005;85:353--4. 8. Mankia SK, Rytina E, Burrows NP. Omeprazole-induced subacute cutaneous lupus erythematosus. Clin Exp Dermato. 2010;35:e1--2. 9. McKeage K, Blick SK, Croxtall JD, Lyseng-Williamson KA, Keating GM. Esomeprazole: a review of its use in the management of gastric acid-related diseases in adults. Drugs. 2008;68:1571--607.